Labguru
BioData has announced that the Innovative Medicines unit of the pharmaceutical giant AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research
BioData has announced that the Innovative Medicines unit of the pharmaceutical giant AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research
Springer has taken control of the journal Autoimmunity Highlights, which was previously owned by A. Menarini Diagnostics, an Italian company
Nature Publishing Group is joining forces with the Breast Cancer Research Foundation (BCRF) to publish NPJ Breast Cancer, an open access research journal which will help us to understand, prevent, treat and cure the disease
IOP Publishing has launched Convergent Science Physical Oncology, said to be the first and only interdisciplinary title dedicated to bringing together all researchers in the field of the physics of cancer
BioMed Central has announced plans to publish the new innovative journal Research Involvement and Engagement, which aims to publish its first articles in June 2015
This week has seen the launch of NPJ Parkinson's Disease, an open access journal entirely dedicated to research aimed at helping the scientific community to understand, mitigate, and eventually cure Parkinson's disease
BioMed Central and the University of Michigan are to publish a new open access journal, Clinical Diabetes and Endocrinology, which is now open for submissions and will begin publishing in the first quarter of 2015
Springer is collaborating with the German Society of Pediatrics and Adolescent Medicine to publish a new open access journal, Molecular and Cellular Pediatrics
Elsevier has added five new subject areas to its Legacy eBook Collection on ScienceDirect. The Legacy Collection consists of digitised, classic scholarly book content, now including nearly 13,000 books
SAGE acquires OA neurochemistry journal
Interviews for this article have been adapted from recent PhaidraCon roundtable events and from upcoming 2023 editions of EpistemiCast
Patrick Hargitt explains why 2022 became the year that accessibility got serious
Joseph Koivisto and Jordan Sly from the University of Maryland discuss the implications of the publications-as-data model
Despite the collective and decisive step changes in enabling the transition to open access this year, we should not be complacent, writes Susie Winter
Thomas Shaw and Andrew Barker from Lancaster University Library discuss the realities, challenges and future impact of open access in the research community
It’s not a question of if, but how. The future of scholarly publishing is open, yet the debate on how to accelerate the growth of open access continues